Obesity and Liver Cancer

Area of Science:

• Hepatology
• Oncology
• Metabolic Disorders

Background:

• Obesity and metabolic disorders are globally prevalent, challenging liver health and increasing cancer risk.
• The
• Non-alcoholic fatty liver disease (NAFLD), linked to obesity, insulin resistance, and type 2 diabetes, is a growing trigger for liver cancer in Western countries, where traditional risk factors like viral hepatitis are less common.

Purpose of the Study:

• To explore the association between obesity and liver cancer risk.
• To identify molecular mechanisms linking obesity to liver cancer.
• To inform liver cancer prevention strategies.

Main Methods:

• Review of accumulating evidence on body mass index (BMI) and liver cancer risk.
• Analysis of associations with abdominal obesity and metabolic factors.
• Investigation of molecular pathways implicated in obesity-associated liver cancer.

Main Results:

• Higher BMI is associated with increased primary liver cancer risk, especially in men, individuals with existing liver disease, and white ethnic groups.
• Abdominal obesity and adult weight gain are suggested risk factors, requiring further study.
• Molecular pathways like insulin resistance, chronic inflammation, and altered gut microbiota are implicated in obesity-driven liver cancer.

Conclusions:

• Obesity is a significant risk factor for liver cancer, driven by metabolic and inflammatory processes.
• Understanding these mechanisms is crucial for developing effective liver cancer prevention strategies.
• Further research is needed to clarify the role of specific obesity indicators and their impact on liver cancer survival.